239 related articles for article (PubMed ID: 17348002)
1. Focal nodular hyperplasia: intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging.
Marin D; Iannaccone R; Laghi A; Catalano C; Murakami T; Hori M; Kim T; Passariello R
J Magn Reson Imaging; 2007 Apr; 25(4):775-82. PubMed ID: 17348002
[TBL] [Abstract][Full Text] [Related]
2. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
Grazioli L; Morana G; Kirchin MA; Schneider G
Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
[TBL] [Abstract][Full Text] [Related]
3. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
Grazioli L; Morana G; Kirchin MA; Caccia P; Romanini L; Bondioni MP; Procacci C; Chiesa A
J Magn Reson Imaging; 2003 May; 17(5):593-602. PubMed ID: 12720270
[TBL] [Abstract][Full Text] [Related]
4. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine.
Grazioli L; Morana G; Federle MP; Brancatelli G; Testoni M; Kirchin MA; Menni K; Olivetti L; Nicoli N; Procacci C
Radiology; 2001 Dec; 221(3):731-9. PubMed ID: 11719669
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Gadolinium-BOPTA and Ferucarbotran-enhanced three-dimensional T1-weighted dynamic liver magnetic resonance imaging in the same patient.
Wersebe A; Wiskirchen J; Decker U; Schick F; Dietz K; Müller-Schimpfle M; Claussen CD; Pereira PL
Invest Radiol; 2006 Mar; 41(3):264-71. PubMed ID: 16481909
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
[TBL] [Abstract][Full Text] [Related]
9. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
Fröhlich JM
J Magn Reson Imaging; 2004 Mar; 19(3):375-6; author reply 376. PubMed ID: 14994308
[No Abstract] [Full Text] [Related]
10. Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas.
Kim YK; Kim CS; Lee YH; Kwak HS; Lee JM
AJR Am J Roentgenol; 2004 May; 182(5):1217-23. PubMed ID: 15100122
[TBL] [Abstract][Full Text] [Related]
11. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
Roux M; Pigneur F; Calderaro J; Baranes L; Chiaradia M; Tselikas L; Decaens T; Costentin C; Laurent A; Azoulay D; Mallat A; Zafrani ES; Rahmouni A; Luciani A
J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
[TBL] [Abstract][Full Text] [Related]
14. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
[TBL] [Abstract][Full Text] [Related]
15. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations.
del Frate C; Bazzocchi M; Mortele KJ; Zuiani C; Londero V; Como G; Zanardi R; Ros PR
Radiology; 2002 Dec; 225(3):766-72. PubMed ID: 12461259
[TBL] [Abstract][Full Text] [Related]
16. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
[TBL] [Abstract][Full Text] [Related]
17. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
[TBL] [Abstract][Full Text] [Related]
18. Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging.
Kim YK; Lee JM; Kim CS; Chung GH; Kim CY; Kim IH
Eur Radiol; 2005 Feb; 15(2):220-8. PubMed ID: 15624108
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
[TBL] [Abstract][Full Text] [Related]
20. Gadobenate-dimeglumine-enhanced magnetic resonance imaging for hepatic lesions in children.
Chavhan GB; Mann E; Kamath BM; Babyn PS
Pediatr Radiol; 2014 Oct; 44(10):1266-74. PubMed ID: 24771094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]